- argenx SE (ARGX) is scheduled to announce Q2 earnings results on Thursday, July 23rd, before market open.
- The consensus EPS Estimate is $6.19 and the consensus Revenue Estimate is $1.43B
- Over the last 3 months, EPS estimates have seen 9 upward revisions and 3 downward. Revenue estimates have seen 7 upward revisions and 9 downward.
More on argenx SE
- argenx SE (ARGX) Discusses R&D Spotlight on Advancing FcRn Leadership in Autoimmune Myositis Transcript
- argenx SE (ARGX) Discusses R&D Spotlight on Advancing FcRn Leadership in Autoimmune Myositis - Slideshow
- argenx SE (ARGX) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
- Argenx wins FDA nod to broaden Vyvgart label in myasthenia gravis
- Argenx targets 2.5x more VYVGART patients by decade-end as Phase III empasiprubart MMN readout nears 4Q